Keyphrases
GABAA
50%
North Sea Progressive Myoclonus Epilepsy
50%
Drosophila Model
50%
Antiseizure Medication
50%
Depressive Symptoms
50%
Anxiety Symptoms
50%
Hyperkinetic Movement Disorders
50%
Comparative Analysis
50%
Quality of Life
50%
Myoclonus Epilepsy
50%
Seizure
25%
Barbital
20%
Seizure Suppression
20%
Ganaxolone
20%
Sodium
20%
Clonazepam
15%
Movement Disorders
11%
Valproic Acid
10%
Ethosuximide
10%
Levetiracetam
10%
Myoclonus
10%
Anxiety-depression
7%
Quality of Life Assessment
7%
Groningen
7%
Disability Paradox
7%
University Medical Centre
7%
Rare Genetic Disease
5%
Days of Treatment
5%
Ataxia
5%
Heat-induced
5%
Third Generation
5%
Clinical Effect
5%
Mode of Action
5%
GOSR2
5%
Homozygous mutation
5%
High Dose
5%
Anticonvulsive
5%
Progressive Myoclonus Epilepsy
5%
Progressive Course
5%
Heat Sensitivity
5%
GABAA Receptor (GABAAR)
5%
Neuroscience
Myoclonus
100%
Anti-Seizure Medication
50%
Antiseizure Medication
50%
Stereotypic Movement Disorder
50%
Depressive Disorder
50%
Barbital
15%
Ganaxolone
15%
Clonazepam
11%
Valproic Acid
7%
Levetiracetam
7%
Ethosuximide
7%
Ataxia
7%
Medicine and Dentistry
Quality of Life
50%
Stereotypic Movement Disorder
50%
Lafora Disease
50%
Depressive Disorder
50%
Barbital
12%
Short Form 36
7%
